Compare

GRI Bio, Inc. vs CNS Pharmaceuticals, Inc. vs IGC Pharma, Inc. vs Palatin Technologies Inc

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearGRI Bio, Inc.
GRI
CNS Pharmaceuticals, Inc.
CNSP
IGC Pharma, Inc.
IGCLast annual report: year ended 2025-03-31
Palatin Technologies Inc
PTN
Year ended2025-12-312025-12-312025-03-312026-06-30
Revenuen/an/a$1.27M$13.19M
Revenue growth (YoY)n/an/a-5.5%n/a
Gross marginn/an/a48.7%n/a
Operating marginn/an/a-585.8%-65.7%
Net marginn/an/a-560.3%-63.5%
Net income-$11.96M-$15.85M-$7.12M-$8.38M
EPS (Diluted)-$121.80-$35.75-$0.09-$2.96
Operating cash flow-$10.19M-$13.81M-$4.79M-$13.53M
Free cash flow-$10.19M-$13.83M-$4.91M-$13.58M
Cash & equivalents$8.23M$7.20M$405.0K$7.49M
Total assets$8.67M$8.62M$8.75M$8.52M
Total liabilities$2.66M$4.10M$2.42M$1.84M
Shareholders' equity$6.01M$4.52M$6.33M$6.69M
Return on year-end equity-199.0%-350.5%-112.5%-125.3%
Shares outstanding497.7K632.5K80.88M1.78M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearGRI Bio, Inc.CNS Pharmaceuticals, Inc.IGC Pharma, Inc.Palatin Technologies Inc
Latest$0
Ended 2021-12-31
n/a$1.27M
Ended 2025-03-31
$13.19M
Ended 2026-06-30
1 year earlier$100.0K
Ended 2020-12-31
n/a$1.34M
Ended 2024-03-31
n/a
2 years earliern/an/a$911.0K
Ended 2023-03-31
n/a
3 years earliern/an/a$397.0K
Ended 2022-03-31
n/a
4 years earliern/an/a$898.0K
Ended 2021-03-31
n/a